William Blair & Company
CLLS

William Blair & Company’s Cellectis CLLS Stock Holding History

William Blair & Company’s Portfolio CLLS Stock Details CLLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-13,650
Closed -$172K – 1977
2021
Q3 		$172K Sell
13,650
-1,500
-10% -$20.8K ﹤0.01% 1532
2021
Q2 		$234K Buy
15,150
+750
+5% +$12.6K ﹤0.01% 1445
2021
Q1 		$291K Buy
14,400
+2,500
+21% +$61.8K ﹤0.01% 1336
2020
Q4 		$322K Buy
+11,900
New +$267K ﹤0.01% 1230

Other funds holding CLLS

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return

William Blair & Company's CLLS Position: Q4 2021 in Review

William Blair & Company sold out of Cellectis (CLLS) in Q4 2021, closing a stake of 13,650 shares — an estimated $172K sold.

William Blair & Company first reported a position in CLLS in Q4 2020 and held it in 4 quarters. The position peaked at $322K in Q4 2020. 57 funds tracked by Wall St. Rank hold CLLS as of Q4 2021.

  • William Blair & Company reported no remaining Cellectis position as of Q4 2021 after selling out during the quarter.
  • William Blair & Company sold 13,650 Cellectis shares in Q4 2021, an estimated $172K.
  • William Blair & Company first reported a position in Cellectis in Q4 2020 and held it in 4 quarters.
  • William Blair & Company's Cellectis position peaked at $322K in Q4 2020.
  • 57 funds tracked by Wall St. Rank held Cellectis as of Q4 2021.

Based on William Blair & Company's 13F filing for Q4 2021, filed 14 Feb 2022.